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MATERIALS & METHODS 
Antibodies and Reagents     
All monoclonal antibodies (mAbs) used for the identification of iNKT cells and iNKT cell 
developmental stages are listed in Supplementary Table 1 and described before [1, 2]. aGalCer 
(KRN7000) was purchased from Funakoshi (Japan). CaspGLOW fluorescein Active Caspase-3 
(FITC-DEVD-FMK) staining kit, EdU, and Click-iT™ Plus EdU Alexa Fluor™ 488 were from 
Invitrogen. PE, APC, or BV421 fluorophore-tagged, mouse CD1d-aGalCer tetramers were 
obtained from the NIH Tetramer Facility (Emory University).   
Generation of BM chimeras      
Recipient Ja18-/- mice were irradiated with a single dose of 950 rads from a cesium source and 
rested for 6—8 hours. B6, Nur77tg, Ja18-/-, Nur77tg;Va14tg and Va14tg mice BM cells (10x106) 
were used as donors for transfer into irradiated Ja18-/- recipients alone (single BM chimeras) or 
mixed at 1:1 ratio with BM cells from Ja18-/- mice (mixed BM chimeras). In some studies, 10x106 
BM cells from CD45.1+ B6, CD45.2+ Va14tg or CD45.2+ Nur77tg;Va14tg mice were transferred into 
irradiated Ja18-/- recipients either alone or mixed in 1:1 ratio with 10x106 BM cells from CD45.1+ 
B6 mice to generate mixed BM chimeras. For limiting dilution studies, 1x106, 5x106 or 10x106 
Ja18-/- BM cells were mixed with 10x106 Va14tg or Nur77tg;Va14tg BM cells.   
Flow Cytometry   
Cells (3x106) from indicated mice were incubated with Ghost Violet 510 viability dye to differentiate 
between live/dead cells. Cells were washed twice with FACS buffer and incubated with FACS 
buffer containing 0.2 µg anti-CD16/CD32 mAb (Fc receptor blocking Ab) followed by surface 
staining with CD1d tetramer and antibodies against mouse CD3e, CD24, CD44 and NK1.1 to 
evaluate iNKT cell developmental stages and caspase 3 activation by iNKT cells as described 
previously [1, 2]. Briefly, iNKT cells were identified as CD3e+tetramer+ cells among B220LOCD8LO 
splenocytes and hepatic mononuclear cells or B220LOCD8LO thymocytes.  
For intracellular detection of cytokines, cells were stained for live dead discrimination and surface 
stained to identify iNKT cells followed by intracellular staining with mAbs against mouse IFN-g, IL-
4, IL-17 or IL-10 using fixation/permeabilization solution kit (BD Biosciences) by following the 
manufacturer’s protocol. For nuclear staining of transcription factors (TFs), dead cell 
discrimination and surface staining were done as above followed by nuclear detection of TFs 
PLZF, Tbet, RORgt, and Foxp3 by using eBiosciences Foxp3/TFs staining buffer set using the 
manufacturer’s protocol. iNKT cell developmental activation profile, stages, subsets were 
phenotyped by using eight to ten color flow cytometry, which was performed with a FACSCanto 
II, LSR-II instrument or Fortessa (Becton-Dickinson). Data were analyzed with FlowJo software 
(Treestar Inc.). Absolute iNKT cell numbers were calculated from % tetramer+ cells and total 
number of cells recovered from each organ. In some experiments (Figure 2B; Supplementary 
Figure 2B) AccuCheck counting beads (Thermo Fisher Scientific) were included in samples to 
allow for calculation of absolute iNKT cell counts as per the manufacturer's instructions.   
Serum cytokine detection    
Animals were injected i.p. with vehicle control or 1 µg aGalCer followed by serum harvest 5—6 
hours after injection. Serum cytokines were estimated using Meso Scale Detection multiplex 
cytokines assay using manufacturer protocols and guidelines.  
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Antigen presentation assay      
DP thymocytes isolated from 5—6-week old Va14tg and Nur77tg;Va14tg mice were flow sorted. 
Purified DP thymocytes (5x105) were incubated with the test Va14+ iNKT cell hybridoma 
(DN32.D3; 5x104) or the control Va3.2+ hybridoma (431-A11; 5x104) cells. Supernatants from the 
co-culture were collected after 24 hours, and IL-2 production was quantified by enzyme-linked 
immunosorbent assay as described [1].   
Apoptosis and cell proliferation assay       
For caspase 3 apoptosis assay, thymocytes and splenocytes (3´106) from indicated mice were 
incubated with FITC labelled caspase 3 (FITC-DEVD-FMK) or control (Z-VAD-FMK) substrates 
for 3 hours. Cells were washed twice (with wash buffer included in CaspGLOW fluorescein active 
caspase assay kit) and incubated with Ghost Violet 510 viability dye. Cells were washed twice 
with FACS buffer and incubated with FACS buffer containing 0.2 µg anti-CD16/CD32 mAb 
followed by surface staining with CD1d tetramer and mAbs against mouse CD3e, CD24, CD44 
and NK1.1 to evaluate caspase 3 activation by total iNKT cells or each developmental stage as 
described previously [1, 2]. For cell proliferation assay, mice were injected i.p. with 1 mg 5-ethynyl-
2- 611 deoxyuridine (EdU) in PBS for 72 hours before analysis. Cells were stained to discriminate 
live from dead cells, and block Fc receptors. Cells were surface stained to identify iNKT cells and 
each developmental stage as above. EdU incorporation was detected with Click-iT™ Plus EdU 
Alexa Fluor™ 488 by following the manufacturer’s protocol. EdU incorporation was analyzed in 
live iNKT cells by flow cytometry.  
Statistics      
Comparisons between three or more groups were performed by one-way ANOVA with Tukey’s 
post test to determine significance. Comparison between two groups was performed by two-tailed, 
unpaired t test. All statistical analyses were performed using Prism software (GraphPad). 
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Figure S1. Constitutive overexpression of Nur77 impairs conventional T cell development. (A) 
Thymic and splenic CD4+ and CD8+ T cells from C57BL/6 (n=5) and Nur77tg (n=4) mice were identified 
within electronically gated CD3e+tetramerNEG thymocytes or B220NEGCD3e+ splenocytes. Numbers are % 
CD4+ or CD8+ T cells among total leukocytes. Data are representative of two independent experiments. (B) 
Absolute cell numbers were calculated by multiplying total cell counts with the frequency (%) of CD4+, CD8+, 
CD4+8+ DP or CD4NEG8NEG DN cells. n, as in A. Data are cumulative mean + sem (standard error of the 
mean) from two independent experiments. (C) Thymic and splenic iNKT cells from C57BL/6 (n=4) and 
Nur77tg (n=4) mice were identified as CD3e+tetramer+ cells within electronically gated CD8lo thymocytes or 
B220lo splenocytes. Numbers are % iNKT cells among total leukocytes within each organ. (D) Absolute cell 
numbers were calculated by multiplying total cell counts with the frequency (%) of % iNKT cells. Data are 
cumulative mean + sem; n, as in C. *P £ 0.05, ***P£0.0001.   
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 Figure S2. Introgression of a rearranged Va14i TCR a-chain gene into Nur77tg mice partially rescues 
iNKT cell development. (A) iNKT cells in thymus from Nur77tg;Va14tg (n=3) and Va14tg (n=3) mice were 
identified as in Fig. S1, and surface stained with mAbs against mouse CCR7 and PD-1. Then they were 
stained with specific mAb for PLZF, T-bet and RORgt. Contour plots show gating strategy to identify PLZHI, 
PLZFINT and PLZFLO (all RORgtNEG) and PLZFHIRORgt+ NKT17 iNKT cells. PLZFHI population were further 
gated to identify CCR7HIPD-1LO and CCR7LOPD-1HI (NKT2) cells. PLZFINTTbetHI NKT1 cells were identified 
by gating for T-bet expression on iNKT cells. Plots are representative of two independent experiments. (B) 
Absolute numbers of iNKT subsets were calculated by multiplying the frequency (%) of iNKT cells with total 
cell number. Data are cumulative mean + sem from two independent experiments. n, as in A. (C,D) iNKT 
cells identified as above from the thymus and spleen of Nur77tg;Va14tg (n=3) and Va14tg (n=3) mice were 
segregated into iNKT subsets, PLZFINTTbetHI NKT1, PLZFHI NKT2, PLZFHIRORgt+ NKT17 cells (C; contour 
plots, left panel), and Nur77 expression monitored. (C) Overlay histograms are representative of two 
independent experiments. (D) gMFI of Nur77 expression by thymic (top panel) and splenic (bottom panel) 
iNKT cell subsets. Data are cumulative mean + sem; n, as in C. ns, not significant (P >0.05), *P £ 0.05, **P 
£0.001, ***P£0.0001. 
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Figure S3. Nur77 overexpression alters peripheral iNKT cells in Nur77tg;Va14tg mice. (A) iNKT cells 
(upper panels) in indicated organs from Nur77tg;Va14tg (n=3) and Va14tg (n=3) mice were identified as in 
Fig. 1A. iNKT cell stages (lower panels) were identified as in Fig. 1C. Contour plots are representative of 
two independent experiments. (B) iNKT cell subsets were identified in spleen, liver, lungs, lymph nodes 
and adipose tissue from Nur77tg;Va14tg (n=3) and Va14tg (n=3) mice as in Fig S2C. Contour plots are 
representative of two independent experiments.  
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Figure S4. Normal CD1d, SLAM receptors, and endogenous agonistic ligand expression. (A,B) 
RORgt levels in DP thymocytes from Va14tg (n=9), Nur77tgVa14tg (n=6) mice are shown; overlay histograms 
(A) and gMFIs indicative of RORgt level (B) are shown. Data are cumulative mean + sem from three 
independent experiments. (C,D) Thymic DP T cells and B220+ cells from Va14tg (n=4), Nur77tgVa14tg (n=3) 
mice were identified within electronically gated CD3e+ tetramerNEG thymocytes and monitored for CD1d 
expression. CD1d-/- mice were used as control. (C) Overlay histograms are representative of three 
independent experiments. (D) gMFI of CD1d expression on DP thymocytes and B220+ cells from thymus 
are shown. Data are cumulative mean + sem; n, as in C. (E—H) Expression of SLAM receptors: SLAM 
(SLAMF1; CD150), Ly108 (SLAMF6; NTB-A), CD319 (SLAMF7; CRACC), CD84 (SLAMF5), Ly9 (SLAMF3; 
CD229), CD48 (SLAMF2) by DP T cells (E,F) and stage 0 iNKT cells (G,H) identified as above were tracked 
on Va14tg (n=3), Nur77tgVa14tg (n=4) mice. Overlay histograms (E,G) and gMFIs (F,H) are shown. Data 
are cumulative mean + sem from two independent experiments. (I) IL-2 production by a Va14+ iNKT cell 
hybridoma DN32.D3 and control Va3.2+ hybridoma 431-A11 co-cultivated with the indicated flow sorted DP 
thymocytes at 10:1 DP thymocytes:hybridoma ration or alone. Data are cumulative mean + sem from two 
independent experiments. ns, not significant (P >0.05), *P £ 0.05, **P £0.001, ***P£0.0001.     
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Figure S5. iNKT cells in Nur77tg;Va14tg mice recognize aGalCer but are hyporesponsive. (A) aGalCer 
or vehicle control was injected i.p. into B6, Nur77tg, Nur77tg;Va14tg and Va14tg mice. Six hours post injection, 
serum was harvested, and cytokines measured using meso scale detection kit. Data are cumulative mean 
+ sem from two independent experiments; B6 (vehicle n=2; aGC n=2), Nur77tg (vehicle n=2; aGC n=2), 
Nur77tg;Va14tg (vehicle n=2; aGC n=4) and Va14tg (vehicle n=2; aGC n=3). (B,C) Splenic iNKT cells from 
Va14tg and Nur77tg;Va14tg mice injected i.p. with vehicle control or 1 µg aGalCer were evaluated for 
intracellular IFN-g and IL-4 expression 6 hours post injection. Contour plots are representative of 3—4 
independent experiments. Va14tg (vehicle n=4; aGC n=4), Nur77tg;Va14tg (vehicle n=4; aGC n=4) (B) and 
% IFN-g+, % IL-4+, and % IFN-g+IL-4+ iNKT cells (C) are shown. Data are mean + sem. ns, not significant 
(P >0.05), *P £ 0.05, **P £0.001. 
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Figure S6. iNKT cells in Nur77tg;Va14tg mice have exhausted phenotype. (A,B) iNKT cells in Va14tg 
(n=3) and Nur77tg;Va14tg (n=3) mice were surface stained with mAbs against mouse PD-1. Then they were 
stained with specific mAb for PLZF, T-bet and RORgt. Contour plots showing gating strategy to identify 
PLZFLO, PLZFINTTbetHI NKT1, PLZFHI NKT2, PLZFHIRORgt+ NKT17 iNKT cells. PD-1 expression was 
monitored on the indicated iNKT cell populations. (A) Overlay histograms are representative of two 
independent experiments. (B) gMFIs of PD1 expression. Data are cumulative mean + sem from two 
independent experiments. (C—D) iNKT cell developmental stages were identified as CD44NEGNK1.1NEG 
stage 1, CD44+NK1.1NEG stage 2, or CD44+NK1.1+ stage 3 in spleen, liver and lungs. (C) Overlay 
histograms are representative of two independent experiments, n as in A. (D) gMFIs of PD1 expression. 
Data are mean + sem from two independent experiments, n as in A *P £ 0.05, **P £0.001. ***P £0.0001.   
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Figure S7. Impaired iNKT cell development in Nur77tg;Va14tg/Ja18-/- mice owes to cell-intrinsic and cell-
extrinsic defects. (A) Analysis of chimeras generated with BM cells from donor B6, Nur77tg, Ja18-/-, 
Nur77tg;Va14tg or Va14tg mice transferred into irradiated Ja18-/- recipients alone (single BM chimeras) or 
mixed with BM from Ja18-/- at 1:1 ratio (mixed BM chimeras). Thymic and splenic iNKT cells from B6 (n=6), 
Nur77tg (n=6), Ja18-/- (n=4), Nur77tg;Va14tg (n=6), Va14tg (n=6) single BM chimeras and B6 (n=5), Nur77tg 
(n=5), Nur77tg;Va14tg (n=25), Va14tg (n=20) mixed BM chimeras were identified as before (rows 1 and 4, 
respectively). iNKT cell developmental stages were identified as stage 0+1, stage 2, and stage 3 in the 
thymus and spleen (rows 2 and 5, respectively). In the thymus, stage 0+1 cells were further gated to 
distinguish stage 0 from stage 1 iNKT cells (row 3). Numbers are % cells among total iNKT cells. 
(B,C)Thymocytes and splenocytes from B6 (n=4), Nur77tg;Va14tg (n=18), and Va14tg (n=14) mixed BM 
chimeras were surface stained to identify iNKT cells, followed by nuclear staining with specific mAb against 
PLZF, T-bet and RORgt. (B) iNKT cell subsets were identified as PLZFINTT-betHI NKT1 (upper panel), 
PLZFHI NKT2, and PLZFHIRORgt+ NKT17 (lower panel) subsets in the thymus and spleen. Numbers are % 
cells among total iNKT cells. Contour plots are representative of 3—5 independent experiments. (C) 
Absolute numbers of NKT1, NKT2 or NKT17 cells were calculated multiplying the absolute iNKT cell 
number with the frequency (%) of NKT1, NKT2 or NKT17 cells in B. Data are mean + sem from three or 
more independent experiments. n, as in B. not significant (P >0.05), **P £0.001, ***P£0.0001.     
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Figure S8. Impaired iNKT cell development in Nur77tg;Va14tg/Ja18-/- mice owes to cell-intrinsic and 
cell-extrinsic defects. (A—C) BM cells from donor CD45.1+ B6 (n=3), CD45.2+ Va14tg (n=2) or CD45.2+ 
Nur77tg;Va14tg (n=2) mice were transferred into irradiated Ja18-/- recipients alone (single BM chimeras) or 
BM cells from CD45.1+ B6 mice were mixed at 1:1 ratio with BM cells from CD45.2+ Va14tg (n=4) or CD45.2+ 
Nur77tg;Va14tg (n=5) mice to generate mixed BM chimeras. (A,B) Thymic CD4+, CD8+, DP, DN T cells and 
splenic CD4+ and CD8+ T cells were identified as in Fig. S1A. Bar graphs show total T cell numbers, which 
was calculated as in Fig. 1B, in CD45.1+ and CD45.2+ gated thymocytes (A) and splenocytes (B). Data are 
mean+sem from 2 experiments. n as in A. (C) Thymic and splenic iNKT cells were identified as before in 
single and mixed BM chimeras. Bar graphs showing absolute iNKT cell numbers in thymus and spleen 
gated for CD45.1 and CD45.2 expression. Data are mean + sem from two experiments. n as in A. (D) BM 
cells (1x106, 5x106 or 10x106) from Ja18-/- mice were mixed with 10x106 BM cells from Va14tg or 
Nur77tg;Va14tg BM cells, yielding 10:1, 5:1, 1:1 ratio of BM cells from the two strains. These were mixed 
and transferred into irradiated Ja18-/- recipients. iNKT cells were identified as in Fig. S1C. Bar graphs show 
absolute iNKT cell number calculated as in Fig. 1D. Data are mean + sem from two experiments 
(Va14tg/Ja18-/- mixed BM chimeras n=4 for each ratio tested; Nur77tg;Va14tg/Ja18-/- mixed BM chimeras 
n=6, 4 and 4, respectively, for 1:1, 5:1 and 10:1 ratio). ns, not significant, P >0.05, **P £0.001, ***P£0.0001. 
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Figure S9. Enhanced iNKT cell apoptosis in Nur77tg;Va14tg/Ja18-/- mixed BM chimeras. (A) 
Thymocytes and splenocytes from Va14tg/Ja18-/- (n=5) single and Nur77tg;Va14tg/Ja18-/- (n=5) mixed BM 
chimeras were treated with fluorescently-tagged, active caspase or control substrates. After four hours, 
iNKT cells and iNKT cell developmental stages were identified and caspase-3 incorporation monitored. (A) 
Contour plots are representative of two independent experiments. (B) Va14tg/Ja18-/- (n=3) and 
Nur77tg;Va14tg/Ja18-/- (n=3) mixed BM chimeras were injected i.p. with 1 mg EdU or PBS control. About 72 
hours later, thymocytes and splenocytes were stained for EdU incorporation at various iNKT cell 
developmental stages. Contour plots are representative of two independent experiments.    
 
  
 
 
13 
 
 
 
Figure S10. iNKT cells in Nur77tg;Va14tg/Ja18-/- mixed BM chimeras respond poorly to in vivo 
aGalCer stimulation. (A) Va14tg/Ja18-/- and Nur77tg;Va14tg/Ja18-/- mixed BM chimeras were injected i.p. 
with vehicle or 1 µg aGC. Spleens were harvested at the indicated times after injection. Splenocytes were 
surface stained to identify iNKT cells and stained with mAb to detect intracellular IFN-g and IL-4. Dot plots 
showing IFN-g+ and IL-4+ iNKT cells. Data are representative of 3—5 independent experiments. n for 3 
hours: Va14tg/Ja18-/- (Veh=3, aGC=3), Nur77tg;Va14tg/Ja18-/- (Veh=5, aGC=7); n for 5 hours; Va14tg/Ja18-
/- (Veh=5, aGC=6), Nur77tg;Va14tg/Ja18-/- (Veh=7, aGC=9). (B) Single Nur77tg BM chimeras or mixed 
Va14tg/Ja18-/- or Nur77tg;Va14tg/Ja18-/- BM chimeras were injected with vehicle or 1 µg aGalCer i.p. 
followed by serum harvest after 6 hours. Serum cytokine levels were determined by meso scale detection 
multiplex cytokine assay. Data are mean + sem. n for Nur77tg single chimera: Veh=2, aGC=3; Va14tg/Ja18-
/- mixed chimera: Veh=3, aGC=3; and Nur77tg;Va14tg/Ja18-/- mixed chimera: Veh=4, aGC=5. ns, not 
significant (P >0.05), *P £ 0.05, **P £0.001, ***P£0.0001. 
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Figure S11. iNKT cells in Nur77tg;Va14tg/Ja18-/- mixed BM chimeras express Treg/NKT10 markers 
(A—C) Surface expression of FR4, NRP, SLAM, Ly108 and CD244.2 on thymic and splenic iNKT cells 
identified as in Fig. 1C was evaluated in Va14tg/Ja18-/- (n=4) and Nur77tg;Va14tg/Ja18-/- (n=6) mixed BM 
chimeras. (A) Overlays are representative of two independent experiments. n as above. (B) Bar graphs 
show % of iNKT cells expressing FR4HI, NRP1HI, Ly108HI, and CD244.2HI iNKT cells in Va14tg/Ja18-/- and 
Nur77tg;Va14tg/Ja18-/- mixed BM chimeras. Data are mean + sem. n as in A. (C) gMFI of FR4, NRP1, 
SLAM, Ly108 and CD244.2 on thymic and splenic iNKT cells in mixed BM chimeras. Data are mean + sem. 
n as in A. ns P >0.05, *P £ 0.05, **P £0.001, ***P£0.0001.     
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Figure S12. Nur77 induces Foxp3+ iNKT cells in Nur77tg;Va14tg/Ja18-/- mixed chimeras. (A) 
Splenocytes from C57BL/6, Nur77tg, Va14tg, and Nur77tg;Va14tg mice injected with vehicle or aGalCer were 
stained to identify iNKT cells and CD4+ T cells as in Fig. S1, and CD25 and Foxp3 expression on iNKT 
cells and CD4+ T cells were monitored. Representative contour plots from three independent experiments 
show CD25 and Foxp3 expression by iNKT cells (upper two rows) and CD4+ T cells (lower two rows). n= 
C57BL/6 (Veh=5, aGC=5), Nur77tg (Veh=3, aGC=4), Va14tg (Veh=4, aGC=4) and Nur77tg;Va14tg (Veh=4, 
aGC=5). (B,C) Thymic and splenic iNKT cells in B6/Ja18-/- (n=2), Va14tg/Ja18-/- (n=7), and 
Nur77tg;Va14tg/Ja18-/- (n=7) mixed BM chimeras generated as in Fig. S4 were identified as in Fig. S1C, 
and surface CD25 and nuclear Foxp3 expression evaluated. (B) Contour plots are representative of three 
independent experiments. n as above. (C) Bar graphs show cumulative mean + sem of % of 
CD25NEGFoxp3+ iNKT cells. n as in A. (D) BM cells from congenically marked donor CD45.1+ C57BL/6 
(n=3), CD45.2+ Va14tg (n=2) or CD45.2+ Nur77tg;Va14tg (n=2) mice were transferred into irradiated Ja18-/- 
recipients either alone (single chimeras), or mixed at 1:1 ratio with BM cells from CD45.2+ Va14tg (n=4) or 
CD45.2+ Nur77tg;Va14tg (n=5) mice to generate mixed BM chimeras. Thymic and splenic iNKT cells were 
identified as in Fig. S1C, and surface CD25 and nuclear Foxp3 expression evaluated. Contour plots are 
representative of two independent experiments. ***P£0.0001.    
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Table S1. List of antibodies used for multiparametric iNKT cells analyses in this study 
Antigen Fluorochrome* Clone Source** 
CD1d-aGalCer 
tetramer   
APC, BV421 Mouse 
CD1d 
in-house [1]; NIH Tetrmer Core 
(Emory University) 
CD3e PE, PerCP-Cy5.5, APC, 
PE-Cy7 
145-2C11 BD Biosciences, BioLegend, Tonbo 
Biosciences 
CD8a FITC, PerCP-Cy5.5, APC-
Cy7 
53-6.7 BD Biosciences, BioLegend, 
eBiosciences 
TCRb BV421, APC-eF780 H57-597 Biolegend, BD Biosceinces 
CD44 FITC, APC-Cy7 IM7 BD Biosciences 
NK1.1 PE, PerCP-Cy5.5, APC, 
APC-Cy7 
PK136 BD Biosciences 
B220 FITC, PerCP-Cy5.5, APC-
Cy7 
RA3-6B2 BD Biosciences 
CD4 FITC, PE, PerCP-Cy5.5 RM4-4 BD Biosciences, BioLegend 
CD69 FITC, PE, PE-Cy7, APC H1.2F3 BD Biosciences 
CD122 FITC TM-b1 Biolegend 
CD24 FITC M1/69 BD Biosciences 
CD25 PE-Cy7 PC61 BD Biosciences 
PLZF PE 9E12 Biolegend 
Nur77 PE 12.14 eBiosciences 
T-bet APC 4B10 BioLegend 
RORgt PerCP-Cy5.5 Q31-378 BD Biosciences 
Foxp3 PE, APC FJK-16s eBiosciences 
PD-1 PE, PE-Cy7, APC 1A12 BioLegend 
CCR7 BV605 4B12 BioLegend 
Cd1d PE 1B1 BD Biosciences 
SLAM (SLAMF1) BV-421 TCF15-
12F12.2 
BioLegend 
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Antigen Fluorochrome* Clone Source** 
Ly108 (SLAMF6) PE 330-AJ BioLegend 
CD319 (SLAMF7) APC $G2 BioLegend 
CD84 (SLAMF5) PE mCD84.7 BioLegend 
Ly9 (SLAMF3) PE Ly9ab3 BioLegend 
CD48 (SLAMF2) APC HM48-1 BioLegend 
IFN-g FITC, APC XMG1.2 BioLegend 
IL-4 PE 11B11 BioLegend 
IL-10 PE JESS-16E3 BioLegend 
IL-17 PE TC11-
188H10.1 
BioLegend 
FR-4 PE 12A5 BioLegend 
NRP-1 BV421 3E12 BioLegend 
CD244.2 APC eBio244F4 eBiosciences 
*APC, allophycocyannin; Cy, cyanine; PE, phycoerythrin; PerCP, peridinin chlorophyll protein; APC-Cy7, 
tandem allophycocyannin-cyanine 7 dye  
**where multiple sources are indicated, the reagent worked equally well from the different sources 
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